Mode
Text Size
Log in / Sign up
N/A N=19 Randomized Treatment

Intensive Home-based Treadmill Training and Walking Attainment in Young Children With Cerebral Palsy

Cerebral Palsy

Enrolled (actual)
19
Serious AEs
0.0%
Results posted
Jul 2020
Primary outcome: Primary: Gross Motor Function Measure Dimension E — 15.6; 12.7; 18.7; 17.1 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
home-based treadmill training (Other); Treadmill (Device)
Age
Pediatric · 1+ yrs
Sex
All
Sponsor
California State University, Sacramento
Primary completion
Sep 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Gross Motor Function Measure Dimension E
15.6; 12.7; 18.7; 17.1; 16.2; 14.1
PRIMARY
Walking Activity Measured by StepWatch
39.43; 25.09; 83.33; 18.01; 132.00; 41.19
PRIMARY
Gross Motor Function Measure Dimension D
5.11; 5.30; 8.22; 8.72; 12.67; 12.94
SECONDARY
Pediatric Evaluation of Disability Index-Mobility Subscale
3.80; 5.44; 6.89; 7.51; 11.63; 14.00
SECONDARY
Timed 10-meter Walk Test
-24.86; -36.23; -28.16; -49.65; -46.99; -38.80
SECONDARY
Peabody Developmental Motor Scales-2 -Locomotion Subscale
5.67; 6.70; 8.33; 9.21; 14.11; 13.99
SECONDARY
1-minute Walk Test
8.28; 7.87; 12.38; 9.48; 15.37; 16.15

Summary

This study is designed to find the optimal dosage of home-based treadmill training needed to accelerate walking onset and to examine the long-term effects on the child's walking activity.

Eligibility Criteria

Inclusion Criteria

  • Signs of walking readiness as demonstrated by the ability to sit for 30 seconds when placed and to take 5 to 7 steps when supported at the trunk or arms.
  • Because young children often are not formally diagnosed with CP until 2 years of age, we will include children
  • who show bilateral impairment (i.e. diplegia and quadriplegia, but not hemiplegia)
  • who demonstrate upper motor neuron signs (i.e. spasticity and/or hyperreflexia)
  • who have been identified as high-risk for a motor disability by a physician

Exclusion Criteria

  • a history of uncontrolled seizures
  • a diagnosis of a genetic disorder
  • cardiac or orthopedic contraindications for standing and walking
  • orthopedic surgery in the past 6 months
  • use of spasticity-reducing medication or Botox injections in the past 6 months
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02424526). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search